Antitumor response elicited by a superantigentransmembrane sequence fusion protein anchored onto tumor cells

Jennifer L. Wahlsten, Charles D. Mills, Sundaram Ramakrishnan

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Superantigens stimulate T cells bearing certain TCR β-chain variable regions when bound to MHC II molecules. We investigated whether the superantigen toxic shock syndrome toxin-1 (TSST1) could induce an antitumor immune response when anchored onto MHC II-negative tumor cells. Our approach was to facilitate association of TSST1 with cell membranes by fusing its coding region to the transmembrane region (TM) sequence of the proto-oncogene c-erb-B-2. TSST1-TM was expressed in bacteria with an N-terminal histidine tag and purified using nickel-agarose affinity chromatography. Purified TSST1-TM added to cultures of several different MHC II-negative tumor cells spontaneously associated with cell membranes, as detected by flow cytometry. Because superantigens can direct cell-mediated cytotoxicity against MHC II- positive cells, a TM fusion protein lacking the TSST1 MHC II binding domain (TSST88-194-TM) was also constructed. Tumor cells precoated with TSST1- TM or TSST88-194-TM stimulated proliferation of human peripheral blood lymphocytes in vitro whereas uncoated tumor cells did not. Mice preimmunized with TSST1-TM- or TSST88-194-TM-coated tumor cells mounted a systemic response that resulted in significant antitumor immunity as measured by regression of a parental tumor challenge. TSST1-TM and TSST88-194-TM fusion proteins represent a useful new strategy for attaching superantigens or potentially other proteins onto tumor cell surfaces without genetic manipulation.

Original languageEnglish (US)
Pages (from-to)6761-6767
Number of pages7
JournalJournal of Immunology
Volume161
Issue number12
StatePublished - Dec 15 1998
Externally publishedYes

Fingerprint

Superantigens
Neoplasms
Proteins
Cell Membrane
Agarose Chromatography
Proto-Oncogenes
Staphylococcal enterotoxin F
Nickel
Affinity Chromatography
Histidine
Immunity
Flow Cytometry
Lymphocytes
Bacteria
T-Lymphocytes

ASJC Scopus subject areas

  • Immunology

Cite this

Antitumor response elicited by a superantigentransmembrane sequence fusion protein anchored onto tumor cells. / Wahlsten, Jennifer L.; Mills, Charles D.; Ramakrishnan, Sundaram.

In: Journal of Immunology, Vol. 161, No. 12, 15.12.1998, p. 6761-6767.

Research output: Contribution to journalArticle

@article{8f6f33b7264d4f8a97c0e86a6cc72dca,
title = "Antitumor response elicited by a superantigentransmembrane sequence fusion protein anchored onto tumor cells",
abstract = "Superantigens stimulate T cells bearing certain TCR β-chain variable regions when bound to MHC II molecules. We investigated whether the superantigen toxic shock syndrome toxin-1 (TSST1) could induce an antitumor immune response when anchored onto MHC II-negative tumor cells. Our approach was to facilitate association of TSST1 with cell membranes by fusing its coding region to the transmembrane region (TM) sequence of the proto-oncogene c-erb-B-2. TSST1-TM was expressed in bacteria with an N-terminal histidine tag and purified using nickel-agarose affinity chromatography. Purified TSST1-TM added to cultures of several different MHC II-negative tumor cells spontaneously associated with cell membranes, as detected by flow cytometry. Because superantigens can direct cell-mediated cytotoxicity against MHC II- positive cells, a TM fusion protein lacking the TSST1 MHC II binding domain (TSST88-194-TM) was also constructed. Tumor cells precoated with TSST1- TM or TSST88-194-TM stimulated proliferation of human peripheral blood lymphocytes in vitro whereas uncoated tumor cells did not. Mice preimmunized with TSST1-TM- or TSST88-194-TM-coated tumor cells mounted a systemic response that resulted in significant antitumor immunity as measured by regression of a parental tumor challenge. TSST1-TM and TSST88-194-TM fusion proteins represent a useful new strategy for attaching superantigens or potentially other proteins onto tumor cell surfaces without genetic manipulation.",
author = "Wahlsten, {Jennifer L.} and Mills, {Charles D.} and Sundaram Ramakrishnan",
year = "1998",
month = "12",
day = "15",
language = "English (US)",
volume = "161",
pages = "6761--6767",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "12",

}

TY - JOUR

T1 - Antitumor response elicited by a superantigentransmembrane sequence fusion protein anchored onto tumor cells

AU - Wahlsten, Jennifer L.

AU - Mills, Charles D.

AU - Ramakrishnan, Sundaram

PY - 1998/12/15

Y1 - 1998/12/15

N2 - Superantigens stimulate T cells bearing certain TCR β-chain variable regions when bound to MHC II molecules. We investigated whether the superantigen toxic shock syndrome toxin-1 (TSST1) could induce an antitumor immune response when anchored onto MHC II-negative tumor cells. Our approach was to facilitate association of TSST1 with cell membranes by fusing its coding region to the transmembrane region (TM) sequence of the proto-oncogene c-erb-B-2. TSST1-TM was expressed in bacteria with an N-terminal histidine tag and purified using nickel-agarose affinity chromatography. Purified TSST1-TM added to cultures of several different MHC II-negative tumor cells spontaneously associated with cell membranes, as detected by flow cytometry. Because superantigens can direct cell-mediated cytotoxicity against MHC II- positive cells, a TM fusion protein lacking the TSST1 MHC II binding domain (TSST88-194-TM) was also constructed. Tumor cells precoated with TSST1- TM or TSST88-194-TM stimulated proliferation of human peripheral blood lymphocytes in vitro whereas uncoated tumor cells did not. Mice preimmunized with TSST1-TM- or TSST88-194-TM-coated tumor cells mounted a systemic response that resulted in significant antitumor immunity as measured by regression of a parental tumor challenge. TSST1-TM and TSST88-194-TM fusion proteins represent a useful new strategy for attaching superantigens or potentially other proteins onto tumor cell surfaces without genetic manipulation.

AB - Superantigens stimulate T cells bearing certain TCR β-chain variable regions when bound to MHC II molecules. We investigated whether the superantigen toxic shock syndrome toxin-1 (TSST1) could induce an antitumor immune response when anchored onto MHC II-negative tumor cells. Our approach was to facilitate association of TSST1 with cell membranes by fusing its coding region to the transmembrane region (TM) sequence of the proto-oncogene c-erb-B-2. TSST1-TM was expressed in bacteria with an N-terminal histidine tag and purified using nickel-agarose affinity chromatography. Purified TSST1-TM added to cultures of several different MHC II-negative tumor cells spontaneously associated with cell membranes, as detected by flow cytometry. Because superantigens can direct cell-mediated cytotoxicity against MHC II- positive cells, a TM fusion protein lacking the TSST1 MHC II binding domain (TSST88-194-TM) was also constructed. Tumor cells precoated with TSST1- TM or TSST88-194-TM stimulated proliferation of human peripheral blood lymphocytes in vitro whereas uncoated tumor cells did not. Mice preimmunized with TSST1-TM- or TSST88-194-TM-coated tumor cells mounted a systemic response that resulted in significant antitumor immunity as measured by regression of a parental tumor challenge. TSST1-TM and TSST88-194-TM fusion proteins represent a useful new strategy for attaching superantigens or potentially other proteins onto tumor cell surfaces without genetic manipulation.

UR - http://www.scopus.com/inward/record.url?scp=0032534732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032534732&partnerID=8YFLogxK

M3 - Article

C2 - 9862706

AN - SCOPUS:0032534732

VL - 161

SP - 6761

EP - 6767

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 12

ER -